The enhancement of cellular SIRT3 by hexafluorine treatment blocked intracellular TGF-β signalling and fibrotic responses and attenuated the activation phenotype of systemic sclerosis fibroblasts, while the accumulation of mitochondrial and cytoplasmic ROS in fibroblasts was reduced (142, 143). Here, SIRT3 is linked to systemic sclerosis.